Valuation: Danaher Corporation

Market Cap 16TCr 15TCr 14TCr 12TCr 23TCr 15,18800Cr 24TCr 1,63300Cr 65TCr 8,15000Cr 61TCr 59TCr 25,81600Cr P/E 2026 *
36.6x
P/E 2027 * 30.6x
Enterprise Value 18TCr 17TCr 15TCr 14TCr 26TCr 17,12000Cr 27TCr 1,84100Cr 73TCr 9,18700Cr 68TCr 67TCr 29,10100Cr EV / Sales 2026 *
6.94x
EV / Sales 2027 * 6.29x
Free-Float
70.36%
Yield 2026 *
0.63%
Yield 2027 * 0.69%
1 day-1.33%
1 week-2.22%
Current month-1.00%
1 month+0.38%
3 months+13.56%
6 months+42.00%
Current year+0.43%
1 week 229.67
Extreme 229.67
237.95
1 month 217.55
Extreme 217.55
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Free

Director

13 0.0000%
30/10/26 Free

Director

193 0.0000%
30/10/26 Free

Director

144 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.33%-2.22%+3.93%+9.95% 16TCr
-1.27%-4.20%+19.46%+46.32% 26TCr
-1.32%-4.95%-20.34%+44.02% 15TCr
-1.47%-0.75%-57.45%-20.08% 6.33TCr
-0.04%+2.29%+24.11%+58.75% 6.16TCr
-0.70%+1.79%+4.62%-12.65% 5.39TCr
-0.60%-4.02%+17.78%+51.43% 4.88TCr
-0.75%-2.32%+2.02%+70.70% 4.85TCr
-1.48%-4.88%+19.51%+70.33% 4.46TCr
-0.07%-1.27%+13.41%+15.35% 3.75TCr
Average -0.90%-0.39%+2.70%+33.41% 9TCr
Weighted average by Cap. -1.09%-0.35%+3.20%+33.91%

Financials

2026 *2027 *
Net sales 2.63TCr 2.39TCr 2.2TCr 1.99TCr 3.76TCr 2,46600Cr 3.89TCr 27TCr 11TCr 1,32300Cr 9.85TCr 9.65TCr 4,19200Cr 2.83TCr 2.57TCr 2.37TCr 2.14TCr 4.05TCr 2,65600Cr 4.19TCr 29TCr 11TCr 1,42500Cr 11TCr 10TCr 4,51400Cr
Net income 439.63Cr 399.41Cr 369.03Cr 333.33Cr 629.06Cr 41TCr 651.18Cr 4.44TCr 1.76TCr 22TCr 1.65TCr 1.61TCr 70TCr 521.52Cr 473.8Cr 437.77Cr 395.42Cr 746.23Cr 49TCr 772.47Cr 5.26TCr 2.09TCr 26TCr 1.96TCr 1.92TCr 83TCr
Net Debt 2.06TCr 1.87TCr 1.73TCr 1.56TCr 2.94TCr 1,93200Cr 3.05TCr 21TCr 8.23TCr 1,03700Cr 7.72TCr 7.56TCr 3,28400Cr 1.61TCr 1.46TCr 1.35TCr 1.22TCr 2.3TCr 1,51000Cr 2.38TCr 16TCr 6.43TCr 81TCr 6.04TCr 5.91TCr 2,56700Cr
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
16/26/16 $229.91 -1.33% 32,33,236
13/26/13 $233.02 +0.37% 33,59,568
12/26/12 $232.16 -1.34% 23,82,361
11/26/11 $235.31 -0.34% 32,28,140
10/26/10 $236.11 +0.42% 33,96,149
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
229.91USD
Average target price
259.90USD
Spread / Average Target
+13.05%